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Abstract. The health effects arising from exposure to low 
doses of ionizing radiation are of particular concern, mainly 
due to the increased application of diagnostic and therapeutic 
X-ray modalities. The mechanisms behind the cell and tissue 
responses to low doses remain to be elucidated. Accumulating 
evidence suggests that low doses of ionizing radiation induce 
activation of the immune response; however, the processes 
involved have yet to be adequately investigated. Monocytes 
are key players in the induction of an immune response. 
Within the context of this study, we investigated the activa-
tion of toll-like receptors (TLRs), mitogen-activated protein 
kinases (MAPKs) and NF-κB signaling in isolated human 
primary monocytes in response to low doses (0.05 and 0.1 Gy) 
and a high dose (1 Gy) of ionizing radiation. Using quantita-
tive RT-PCR and ELISA techniques, our results showed a 
positive regulation of TLR signaling in response to low doses 
but a less significant response at high doses. This activa-
tion was demonstrated via the activation of TLR signaling 
molecules (HMGB1, TLR4, TLR9, MyD88 and IRAK1). 
Furthermore, and in contrast to the high dose, the low doses 
showed increased phosphorylation levels of the protein IκBα, 
and therefore positive signaling of the NF-κB pathway. This 
result denotes pro-survival and pro-inflammatory responses. 
Additionally, MAPKs were activated in response to 0.05 Gy, 
while 0.1 and 1 Gy showed a downregulatory trend that may 
be related to activation of the PF4 gene. On the other hand, 
there was highly significant involvement of activated p53 
and damaged genes in response to high but not low doses. 
In conclusion, this study addressed the need to re-evaluate 
health risks arising from exposure to low doses of ionizing 
radiation, particularly in view of the accumulating evidence 
reporting inflammatory and oncogenic consequences from 
these exposures.
Introduction
There is increasing concern regarding the health risks arising 
from exposure to low doses of ionizing radiation, particularly 
within the medical diagnostic and therapeutic fields (1,2). One 
of the challenging factors in the study of the health effects 
of exposures to low doses of ionizing radiation is the lack of 
epidemiological data, primarily due to confounding factors 
related to inter-individual variability, life style, and genetic 
background (3). Furthermore, in contrast to the well-studied 
mechanisms and the thoroughly investigated health effects 
of high doses, where cancer is a well-validated endpoint, the 
mechanisms and the biological responses, induced by low 
doses of ionizing radiation, are largely not agreed upon in the 
published studies (4).
Previously, we demonstrated that low doses of ionizing 
radiation induce immune responses in whole blood samples, 
with the gene set enrichment analysis showing the involve-
ment of both innate and adaptive immunity (5). Monocytes 
are key players in the immune response. These cells origi-
nate from the bone marrow and are then released into the 
bloodstream following maturation, while in tissues, they 
differentiate into macrophages and myeloid dendritic cells 
(DCs) (6). Monocytes are important in antigen presentation, 
release of immune-regulatory cytokines, T-cell stimulation 
and differentiation, thus orchestrating the immune system in 
response to ̔attacking signals̛ (7). Toll-like receptors (TLRs) 
are crucial in initiating an immune response in monocytes. 
TLRs are involved in connecting the innate and adaptive 
immune responses together and activating monocytes to 
secrete pro-inflammatory cytokines (8,9). In humans, there 
are 10 characterized TLRs (TLR 1-10). They interact with 
evolutionary conserved pathogen-associated molecular 
patterns (PAMPs), such as lipopolysaccharides (LPS), but also 
with endogenous stress signals, known as danger-associated 
molecular patterns (DAMPs), including fibrinogen, heat shock 
proteins, high mobility group B1 (HMGB1) protein, as well as 
extracellular matrix components (10). Four adapter proteins 
play a key role in the signaling of TLR pathways: MyD88, 
Low doses of ionizing radiation induce immune-stimulatory 
responses in isolated human primary monocytes
HOUSSEIN EL-SAGHIRE1,2,  ARLETTE MICHAUX1,  HUBERT THIERENS2  and  SARAH BAATOUT1,3
1Radiobiology Unit, Molecular and Cellular Biology, Belgian Nuclear Research Centre (SCK-CEN), 
2400 Mol; 2Department of Basic Medical Sciences, Faculty of Medicine and Health Sciences; 
3Department of Molecular Biotechnology, Ghent University, 9000 Ghent, Belgium
Received July 29, 2013;  Accepted September 2, 2013
DOI: 10.3892/ijmm.2013.1514
Correspondence to: Dr Houssein El-Saghire, Radiobiology Unit 
Molecular and Cellular Biology, Belgian Nuclear Research Centre 
(SCK-CEN), Boeretang 200, Mol 2400, Belgium
E-mail: hesaghir@sckcen.be
Key words: low dose, ionizing radiation, human primary 
monocytes, inflammatory response, NF-κB, MAPK, TLR, high 
dose, damage
EL-SAGHIRE et al:  LOW DOSES OF IONIZING RADIATION ARE IMMUNE-STIMULATORY IN MONOCYTES1408
Tirap, Trif and Tram. These pathways activate the signaling of 
the transcription factors NF-κB, activator protein 1 (Ap-1) and 
interferon factors (IRF) 3 or 7. MyD88 pathway is the major 
signaling adapter, and is involved in the promotion of NF-κB 
translocation into the nucleus and activation of mitogen-acti-
vated protein kinases, leading to growth factors and cytokine 
secretion (8,11).
In this study, we investigated the activation of different 
TLRs in response to low and high doses of ionizing radia-
tion by measuring the expression of TLR2, TLR9 as well as 
TLR4, a key monocyte TLR. The three receptors were chosen 
as they share a common DAMP (HMGB1), and due to the 
mounting evidence of their involvement in response to radia-
tion stresses (12-14). Furthermore, the investigation included 
downstream signaling pathways; in particular, MAPKs, a 
group of serine/threonine protein kinases involved in a wide 
variety of cell processes, such as cell differentiation, prolif-
eration, apoptosis, as well as in the secretion of inflammatory 
cytokines. There are three major MAPK pathways: the extra-
cellular-signal-regulated-kinase (ERK), the Jun N-terminal 
kinase (JNK) and the p38 pathways (15). We also evaluated the 
phosphorylation levels of IκBα, a protein that sequesters NF-κB 
in the cytoplasm and prevents its translocation to the nucleus 
(16). The results showed an immune-stimulatory response 
at low doses of ionizing radiation through the involvement 
of TLR4 axis of signaling (HMGB1-TLR4-MyD88-IRAK1). 
This observation was confirmed by the activation of MAPK 
and NF-κB signaling. By contrast, high doses predomi-
nantly exhibit a damaging response, through the induction 
of classical ionizing radiation damage and stress genes 
(CDKN1A, POLH, DDB2 and AEN) and activation of the 
p53 protein. Furthermore, the immune-suppressive response 
was demonstrated, mainly via the suppression of NF-κB and 
MAPK signaling.
Materials and methods
Monocyte isolation, culture and irradiation. After signing an 
informed consent form, 48 ml of peripheral blood was obtained 
from 8 healthy donors in EDTA vacutainer tubes. The whole 
blood samples were divided into three different 50 ml Falcon 
tubes (16 ml/tube), and 160 µl of 100 mM EDTA and 800 µl 
of Rosettesep™ Human Monocyte Enrichment Cocktail 
(StemCell™ Technologies, Vancouver, BC, Canada) were 
added to each tube, according to the manufacturer's instruc-
tions. Blood was diluted at 1:1 with phosphate-buffered saline 
(PBS) (Gibco-BRL, Ghent, Belgium) supplemented with 2% 
heat-inactivated fetal bovine serum (FBS) (Gibco-BRL) and 
1% 100 mM EDTA (Invitrogen Life Technologies, Carlsbad, 
CA, USA). The diluted whole blood samples (32 ml) were trans-
ferred into SepMate™-50 tubes (StemCell™ Technologies) 
and layered over 15 ml of density gradient medium, Ficoll-
Paque™ PLUS (GE Healthcare, Uppsala, Sweden), according 
to the manufacturer's instructions. SepMate™-50 (StemCell™ 
Technologies) tubes were centrifuged at 1,200 x g for 10 min 
at room temperature. The top layer, containing the monocytes, 
was transferred into a new tube and washed three times with 
the washing buffer. All the washing steps were performed at 
350 x g for 8 min with brakes off. The cells were counted using 
a Moxi Z Mini Automated Cell Counter (Orflo Technologies, 
Hailey, ID, USA). Cells (1.2x106) were then cultured in each 
of the 6-well plates (Grenier Bio-One, Wemmel, Belgium) 
at a concentration of 5x105 cells/ml of RMPI-1640 medium 
(Gibco-BRL) supplemented with 20% heat-inactivated FBS 
(Gibco-BRL) and 1% penicillin-streptomycin (100 U/ml 
penicillin, 0.1 mg/ml streptomycin) (Invitrogen Life Sciences, 
Ghent, Belgium). The culture plates were exposed at room 
temperature to sham irradiation (control) or to three different 
X-ray doses (0.05, 0.1 and 1 Gy), at a rate of 30 mGy/min 
(250 kV, 1.6 mA, 1 mm Cu). Subsequently, the cultured plates 
were incubated for 6 h at 37˚C in a humidified incubator with 
5% CO2.
RNA isolation, cDNA synthesis and quantitative RT-PCR 
(qRT-PCR). Adherent cells were scraped using Mini Cell 
Scrapers (Biotium, Hayward, CA, USA) and washed three 
times with PBS (Gibco-BRL). All the washing steps were 
performed at 350 x g for 8 min, then suspended in 350 µl of 
lysis buffer (RLT buffer + 10 µl/ml of β-mercaptoethanol) 
provided in the RNeasy® Mini Kit (Qiagen, Germantown, 
MD, USA). Lysates were stored at -80˚C until processed. 
RNA was isolated using the RNeasy® Mini Kit (Qiagen) 
following the manufacturer's instructions. RNA quantity 
was measured using a NanoDrop 2000 Spectrophotometer 
(Thermo Scientific, Aalst, Belgium). The quality was assessed 
with Agilent 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA), and average RIN was 8.9±0.5. For qRT-PCR 
experiments, we selected six different genes belonging to TLR 
signaling (HMGB1, TLR4, TLR9, TLR2, IRAK1 and MyD88) 
and four genes belonging to damage response (CDKN1A, 
POLH, DDB2 and AEN), as well as the PF4 gene, shown to 
be involved in MAPK signaling. RPLP0 was used as a house-
keeping gene. Briefly, cDNA was prepared from 200 ng of 
total RNA using SuperScript® Vilo™ Master Mix (Invitrogen 
Life Technologies) following the manufacturer's instructions. 
RT-PCR was performed using TaqMan® Gene Expression 
Assays (Applied Biosystems, Grand Island, NY, USA). Each 
assay comprised two gene-specific primers and TaqMan 
assay: FAM (6-carboxyfluorescein) labeled with MGB (minor 
groove binder) probe. Each TaqMan assay was run in duplicate 
for each diluted cDNA sample using TaqMan® Fast Advanced 
Master Mix (Applied Biosystems). The reactions were run 
on 7500 Fast Real-Time PCR system (Applied Biosystems) 
following the manufacturer's recommended PCR program: 
95˚C for 20 sec, followed by 40 cycles of 95˚C for 3 sec and 
60˚C for 30 sec. Relative expression values were calculated by 
the Pfaffl method (17).
Protein extraction, quantification and ELISA assay. Adherent 
cells were scraped using Mini Cell Scrapers (Biotium) and 
washed three times with PBS (Gibco-BRL). All the washing 
steps were performed at 350 x g for 8 min, then lysed with 
Lysis Mix provided in Abcam PhosphoTracer kits (Abcam®, 
Cambridge, UK) following the manufacturer's instructions. 
Proteins were quantified using Quick Start™ Bradford Protein 
Assay (Bio-Rad, Hercules, CA, USA) following the manufac-
turer's instructions. Proteins were stored at -80˚C until assays 
were performed. Quantitative measurements of the proteins 
of interest were performed using a PhosphoTracer ELISA 
kit (ab119661) for the measurement of phosphorylated IκBα 
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(Ser32/36) (Abcam®), PhosphoTracer ELISA kit (ab119674) for 
the measurement of phosphorylated ERK (Thr202/Tyr204), 
p38 MAPK (Thr180/Tyr182) and JNK 1/2/3 (Thr202/Tyr185) 
(Abcam®) and PhosphoTracer ELISA kit (ab119666) for the 
measurement of phosphorylated p53 (Ser15). The immuno-
sandwich ELISA assay was performed according to the 
manufacturer's instructions. Fluorescence signals were 
measured using the microplate reader Fluoroskan Ascent CF 
(Thermo Labsystems, Franklin, MA, USA) with an excitation 
filter of 544 nm and an emission filter of 590 nm. To obtain 
protein fold changes, the fluorescence signals from irradiated 
samples were normalized to their matching sham-irradiated 
controls.
Statistical analysis software and graphical representation. 
For statistical analysis, normality was checked using the 
D'Agostino and Pearson omnibus normality test. Statistical 
significance was estimated using the Friedman test or repeated 
measures ANOVA and Dunn's or Tukey tests for multiple 
comparison. P<0.05 was considered to indicate statistical 
significance. Statistical analysis and graphical representation 
were performed using the GraphPad Prism 5 program.
Results
Cultured monocytes. Monocytes were isolated and purified 
from human whole blood samples using density gradient 
centrifugation and human monocyte enrichment anti-
body cocktail. The average number of purified cells was 
375±83x103 cells/ml whole blood. Results of the trypan blue 
staining showed that at least 95% of the cells cultured for 6 h 
were viable.
Low doses of ionizing radiation induced the TLR signaling 
axis. Monocytes were activated via the induction of TLR 
signaling. Our results showed a significant upregulation of 
TLR4 at 0.05 Gy (Fig. 1A). Furthermore, there was a signifi-
cant upregulation of TLR9 at 0.1 Gy (Fig. 1B). TLR2 did 
not show any significant changes in response to any of the 
doses (Fig. 1D). TLR2, 4 and 9 interact with the endogenous 
molecule HMGB1, which is secreted by activated monocytes 
or released due to increased damage. All the doses showed 
increased levels of HMGB1 (Fig. 1C).
Adapter molecules are important in initiating the signal 
transduction of the activated TLRs. One of the key adapter 
molecules is MyD88. TLR 2, 4 and 9 signaling is known to be 
mediated via MyD88. Although our results demonstrated an 
upregulatory trend for all the doses, only the samples irradi-
ated with 0.05 Gy achieved statistical significance (Fig. 2A). 
IRAK1 interacts with MyD88 for further promotion of TLR 
signaling, leading to the activation of NF-κB and MAPKs. Our 
results showed an upregulation in the levels of IRAK1 at 0.05 
and 0.1 Gy, but not at 1 Gy (Fig. 2B).
Low doses of ionizing radiation induced positive NF-κB 
signaling and MAPK activation. IRAK1 is known to interact 
with IκBα, which is a protein that sequesters the NF-κB tran-
scription factor in the cytoplasm and prevents its translocation 
to the nucleus. Following activation of NF-κB signaling, IκBα 
is phosphorylated and degraded. Phosphorylation at Ser32/36 
is essential for the release of NF-κB and it is considered a good 
marker for NF-κB activation. Our results showed upregulation 
in the phosphorylation of IκBα at 0.05 and 0.1 Gy and down-
regulation in the phosphorylation levels at 1 Gy (Fig. 3A). In 
addition to that, MyD88-IRAK1 signaling molecules promote 
Figure 1. Toll-like receptors and HMGB1 are activated in response to ionizing radiation. Comparative qRT-PCR results of (A) TLR4, (C) TLR2 and (D) TLR9 
and their interaction molecule (B) HMGB1 in response to low and high doses of ionizing radiation. The chart shows the mean values and the standard error of 
the mean. Statistical significance was calculated by applying the Friedman test followed by Dunn's multiple comparison test. P<0.05 was considered statisti-
cally significant. *P<0.05; **P<0.005.
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the activation of MAPKs. These are serine/threonine protein 
kinases that are activated subsequent to phosphorylation. The 
three major MAPKs are p38, ERK and JNK. Our results showed 
an upregulation of the phosphorylated form, thus the activated 
form, of the three MAPKs in response to 0.05 Gy (Fig. 3B, C 
and D). By contrast, higher doses (0.1 and 1 Gy) exhibited a 
downregulation of the three MAPKs (Fig. 3B, C and D). To 
investigate the responses of the MAPKs at different doses, 
we measured the levels of PF4 gene. PF4 (platelet factor 4) is 
known to induce the activation of MAPKs (p38, ERK and JNK) 
in monocytes. The expression levels were in agreement with 
the phosphorylation levels of the proteins; PF4 showed lower 
induction at 0.1 and 1 Gy with significant statistical difference 
between 0.05 Gy in comparison to 0.1 and 1 Gy (Fig. 4).
High doses of ionizing radiation induced damage responses 
and p53 activation. Samples irradiated with 1 Gy showed a 
Figure 2. Molecules downstream of TLRs were activated in response to low doses of ionizing radiation. Comparative qRT-PCR results of the adapter molecule 
MyD88 (A) and IRAK1 (B). The chart shows the mean values and the standard error of the mean. Statistical significance was calculated by applying the 
Friedman test followed by Dunn's multiple comparison test. P<0.05 was considered statistically significant. *P<0.05; **P<0.005.
Figure 3. Low doses of ionizing radiation induced pro-survival and pro-inflammatory responses. Fold changes of the phosphorylated forms of the proteins 
(A) IκBα, (B) p38, (C) ERK 1/2 and (D) JNK 1/2/3. The chart shows the mean values and the standard error of the mean. Statistical significance was calculated 
by applying one-way repeated measures ANOVA followed by the Tukey's test for multiple comparisons. P<0.05 was considered statistically significant. 
*P<0.05; **P<0.005; ***P<0.0001.
Figure 4. PF4 gene was downregulated in response to 0.1 and 1 Gy X-rays. 
Comparative qRT-PCR results of the PF4 gene in response to low and high 
doses of ionizing radiation. The chart shows the mean values and the stan-
dard error of the mean. Statistical significance was calculated by applying 
the Friedman test followed by Dunn's multiple comparison test. P<0.05 was 
considered statistically significant. *P<0.05. 
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significant upregulation of the four genes involved in response 
to stress and damage (Fig. 5). These included cyclin-dependent 
kinase inhibitor 1A (CDKN1A), which plays a role in cycle arrest 
in response to DNA damage. It showed a statistical significance 
at 1 Gy compared to the sham-irradiated samples and between 
the different irradiation doses, i.e., between 0.05 and 1 Gy, but 
also between 0.1 and 1 Gy (Fig. 5A). Additionally, polymerase 
DNA-direct η (POLH), a gene that plays a role in DNA repair 
in response to DNA damage was upregulated exclusively at 
1 Gy. A statistically significant difference between 1 Gy in 
comparison to 0.05 and 0.1 Gy (Fig. 5B) was observed. Another 
DNA damage and repair gene, DNA damage binding protein-2 
(DDB2), showed a similar expression profile to that of POLH. 
It showed statistical significance in response to 1 Gy compared 
to the sham-irradiated samples with a statistical difference 
between 1 Gy, compared to 0.05 and 0.1 Gy (Fig. 5C). The pro-
apoptotic gene apoptosis enhancing nuclease (AEN) showed 
an upregulatory trend at low doses (0.05 and 0.1 Gy) without 
achieving statistical significance; however, it was significantly 
upregulated in response to 1 Gy (Fig. 5D). Furthermore, the 
phosphorylated form of p53 showed a significant upregulation 
in response to 1 Gy in comparison to the sham-irradiated 
samples, with a statistical significance between the induced 
levels at 0.05 and 1 Gy (Fig. 6).
Discussion
Gaining a better understanding of the mechanisms involved in 
cell and tissue responses to low doses of ionizing radiation is of 
increased interest as medical diagnostic and therapeutic appli-
cations involving X-rays are significant contributory factors to 
the cumulative doses of the general population (18). Previously, 
whole genome expression studies showed that high doses of 
ionizing radiation predominantly induced DNA damage and 
apoptosis with p53 signaling playing a key role, while low 
doses induced mainly cytokine and chemokine signaling 
(5). To clarify the mechanisms behind this immune response 
induction, we investigated the activation of central immune 
pathways in the primary human monocytes following exposure 
Figure 5. Cell cycle arrest, DNA damage and apoptosis were induced in response to 1 Gy X-rays. Comparative qRT-PCR results of (A) CDKN1A, (B) POLH, 
(C) DDB2 and (D) AEN in response to low and high doses of ionizing radiation. The chart shows the mean values and the standard error of the mean. Statistical 
significance was calculated by applying the Friedman test followed by Dunn's multiple comparison test. P<0.05 was considered statistically significant. 
*P<0.05; **P<0.005; ***P<0.0001.
Figure 6. The phosphorylated form of p53 was induced in response to 1 Gy 
X-rays. Fold changes of the phosphorylated form of the protein p53. The 
chart shows the mean values and the standard error of the mean. Statistical 
significance was calculated by applying one-way repeated measures ANOVA 
followed by Tukey's test for multiple comparisons. P<0.05 was considered 
statistically significant. *P<0.05; **P<0.005.
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to low and high doses of ionizing radiation. Our results showed 
immune-stimulatory and pro-survival responses at low doses 
via the involvement of the TLRs, MAP kinases and positive 
regulation NF-κB signaling pathways. On the other hand, a 
dose of 1 Gy showed less involvement of the pro-survival and 
pro-inflammatory pathways, of NF-κB signaling and MAP 
kinase activation; however, damage responses were induced.
TLR4 plays a crucial role in activating monocytes and in 
initiating an innate immune response. TLR4 detects lipopoly-
saccharides (LPS) and mediates its signal transduction via 
CD14 receptors (10). Our results have shown that low doses 
of ionizing radiation induced the activation of TLR4, while 
there was no significant change in its expression following 
exposure to 1 Gy (Fig. 1A). Previously, it has been reported 
that doses in the range of 0.075-2 Gy increased the expres-
sion of TLR4-MD2 in mouse macrophages (12). Additionally, 
TLR4 was shown to be involved in the induction of radia-
tion resistance (19), cell proliferation and the promotion of 
radiation-induced lymphomas (20), as well as the promotion 
of reactive oxygen and nitrogen species (ROS/RNS) causing 
the aggravation of chronic inflammatory diseases (21). 
One of the novel activators of TLR4 is HMGB1 (22). The 
expression of HMGB1 increased significantly at all doses 
(Fig. 1B). Principally, HMGB1 is a nuclear DNA binding 
protein that plays a role in the stabilization of chromosomes 
and transcription regulation. However, recently, the role 
of HMGB1 extended to include inflammation and necrosis 
(22). Activated monocytes and macrophages secrete HMGB1 
and promote immune-stimulatory signaling (23). On the 
other hand, damaged cells ‘passively’ release HMGB1 into 
the extracellular environment (24), which could explain 
the dose-dependent response demonstrated in our data 
(Figs. 1B and 7). Another TLR that is known to interact 
with HMGB1 is TLR2 (25). Results of the present study did 
not show any significant changes in the expression of TLR2 
at all doses (Figs. 1C and 7). It has been reported that the 
interaction between HMGB1 and TLR2 is structurally and 
mechanistically different to TLR4 as TLR2 interacts only 
with nucleosome-bound HMGB1 proteins (26). 
Bacterial CpG DNA sequences and DAMPs, including 
HMGB1, activate TLR9 (10,13). Our results showed an 
upregulatory trend of TLR9 at all doses (Figs. 1D and 7). 
Ermakov et al (27,28) showed that irradiation of lymphocytes 
and endothelial cells with 0.1 Gy led to the secretion of extra-
cellular DNA fragments, which promotes the activation of 
TLR9. Furthermore, they reported that these DNA fragments, 
along with TLR9, played a role in bystander signaling between 
irradiated and non-irradiated cells.
Downstream of the TLR signaling, the MyD88 adapter 
molecule is known to be crucial for the secretion of pro-
inflammatory cytokines, such as IL-12 and IL-18 (29,30). 
MyD88 is involved in the downstream signaling of TLR4 and 
TLR9. It showed statistically significant overexpression in 
response to 0.05 Gy, while the two other doses (0.1 and 1 Gy) 
were upregulatied without reaching statistical significance 
(Figs. 2A and 7).
Following activation, MyD88 interacts with the IRAK1 
molecule, which plays a role in releasing the NF-κB transcrip-
tion factor via the phosphorylation of the sequestering protein 
IκBα (31). IRAK1 was overexpressed significantly at 0.05 and 
0.1 Gy but not at 1 Gy (Fig. 2B). Furthermore, the downstream 
molecule IκBα was upregulated by 2- and 2.5-fold changes 
at 0.05 and 0.1 Gy, respectively (Figs. 3A). By contrast, the 
phosphorylation levels of IκBα exhibited a dephosphorylation 
pattern in response to 1 Gy (Fig. 3A). The positive regulation 
of NF-κB signaling at low doses indicates the promotion of 
pro-survival and pro-inflammatory responses, whereas the 
suppression of NF-κB signaling at high doses indicates a pro-
apoptotic response (16). 
MAPKs such as p38, ERK 1/2 and JNK, are activated 
downstream of the HMGB1-TLR4-MyD88-IRAK1 signaling 
axis (15). Our results showed increased fold changes of phos-
phorylation, thus activation, of the three MAPKs at 0.05 Gy 
(Fig. 3B-D). However, and in contrast to our expectations, 
the phosphorylation levels did not show any increased fold 
changes at 0.1 Gy, which showed a similar response to that 
of 1 Gy (Fig. 3B-D). Previously, we have demonstrated that 
Figure 7.  Schematic representation of the mechanisms involved in the induc-
tion of immune responses after exposure to a low (0.05 Gy) and a high dose 
(1 Gy) of ionizing radiation. The dashed arrows represent 0.05 Gy, while 
the complete arrows represent 1 Gy. The direction of the arrows indicates 
the regulation status. Low doses of ionizing radiation induce TLR4 but not 
TLR2. TLR2, 4 and 9 are known to interact with HMGB1, leading to the 
activation of TLR signal transduction. The adapter molecule MyD88 plays a 
central role in the activation process, as it interacts with different molecules, 
such as IRAK1, which is involved in releasing NF-κB transcription factor, 
thus facilitating its translocation to the nucleus via the phosphorylation of 
IκBα. Downstream IRAK1, MAPKs (p38, ERK and JNK) are activated, 
thus promoting pro-inflammatory signaling. PF4 is involved in the activation 
of MAPKs in monocytes. NF-κB and MAPKs signaling were activated at 
low but not high doses; activation of these pathways stimulate inflamma-
tory and survival responses. HMGB1, high mobility group binding protein 1; 
TLR, toll-like receptor; MAPKs, mitogen-activated protein kinases; 
PF4, platelet factor 4.
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PF4 gene was upregulated in whole blood samples exposed to 
low doses of ionizing radiation (5). PF4 encodes for the platelet 
factor-4 protein, a chemokine expressed in platelets, T cells, 
monocytes, endothelial and muscle cells (32). In monocytes, 
it induces phagocytosis and activates MAPK family proteins 
(p38, ERK and JNK) leading to ROS formation (33). Our 
results showed a significant downregulation in PF4 at 0.1 and 
1 Gy compared to 0.05 Gy (Figs. 4 and 7). This result is in 
agreement with the activated MAPK levels measured at the 
protein levels. This suggests a role of PF4 in the activation or 
suppression of MAPKs in response to ionizing radiation. 
Previously, we have reported that MAPK cascades play a 
central role in whole blood samples irradiated with 0.05 Gy 
(5). In addition to that, studies on exposure to low doses have 
reported a proliferative response through the activation of ERK 
1/2, p38 and JNK (34,35). A study by Kim et al (36) showed 
that in normal diploid cells, there is a transient phosphorylation 
of ERK 1/2 and p38 but not JNK 1/2 in response to 0.05 Gy 
of γ-irradiation, which was accompanied with the activation of 
several downstream transcription factors that promote growth 
signaling, including Elk-1, p90RSK and ATF-2. Another study 
performed by Liang et al (37) showed that MAPK proteins 
c-Raf, ERK 1/2 and MEK 1/2 were activated in mesenchymal 
stem cells in response to 0.075 Gy of X-rays, thus a prolifera-
tive response was concluded.
In contrast to results obtained at the exposure dose of 
0.05 Gy, our results showed suppressed MAPKs levels 
after exposure to 1 Gy (Fig. 3B-D). Tsukimoto et al (38) 
demonstrated that increased levels of MAPK phosphatase-1 
(MKP-1) promote dephosphorylation of p38 and ERK1/2 in 
the macrophage cell line (RAW2674.7) irradiated with 0.5-1 
Gy γ-irradiation. In addition to that, studies performed by 
Lödermann et al (39) demonstrated a decreased induction of 
NF-κB and p38 in response to 0.5-0.7 Gy of γ-irradiation. 
However, our results demonstrated that the damage 
responses were very prominent in response to 1 Gy. CDKN1A 
(Fig. 5A) a cell cycle arrest inducer gene; POLH (Fig. 5B) and 
DDB2 (Fig. 5C), DNA damage and repair genes; and AEN, 
(Fig. 5D) a pro-apoptotic gene, were shown to be exclusively 
induced in response to 1 Gy. These genes were extensively 
validated in response to ionizing radiation (40-44) and shown 
to be activated in response to p53 signaling (45), where as our 
results showed upregulation in the phosphorylated form of 
p53 in response to 1 Gy (Fig. 6). Altogether, the 1 Gy results 
demonstrate immuno-suppressive and damaging responses.
In conclusion, we have demonstrated that monocytes 
exposed to low doses of ionizing induce immune-stimulatory 
and pro-survival responses, while those exposed to high 
doses induced immuno-suppressive and damaging responses. 
Low-dose responses were transduced via the TLR4 signaling 
axis, i.e., HMGB1-TLR4-MyD88-IRAK1-MAPKs-NF-κB, 
which showed a particular upregulation in response to 
0.05 Gy. By contrast, the same axis did not demonstrate 
similar induction in response to 1 Gy. Of note, 0.1 Gy showed 
a ‘borderline’ immune-stimulatory response between low and 
high doses, i.e., TLRs and NF-κB signaling were upregulated 
but not MAPKs. On other hand, damaged genes and p53 were 
exclusively involved in response to 1 Gy but not at lower doses 
(Fig. 8). In view of these results, we clearly address the neces-
sity to consider the health risks that can be induced in response 
to low doses of ionizing radiation, with the TLR, NF-κB and 
MAPK signaling pathways being involved in tumor prolifera-
tion, autoimmunity and chronic inflammation (15,16,22,46). 
Furthermore, there is accumulation of evidence that has 
demonstrated an increased cancer risk due to exposure to low 
doses from medical diagnostics. Thus, there is a need for the 
re-evaluation of the radiation protection measures within the 
medical field.
Acknowledgements
The authors are thankful to all the blood donors and SCK-CEN 
medical staff who kindly accepted to participate in our study. 
In addition, we appreciate Dr P. Willems [Federal Agency for 
Nuclear Control (FANC), Belgium] for the useful scientific 
discussions carried out through the preparation of the study. 
H. El-Saghire is supported by a doctoral SCK-CEN/Ghent 
University grant. This study was funded by the FANC 
CT-SCAN contract (CO-90-09-2329-00) and by the FP7 EU 
EPI-CT contract (grant agreement 269912).
Figure 8. Venn diagram comparing different genes and proteins induced in response to low (0.05 Gy) and high (1 Gy) doses of ionizing radiation.
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